Concepedia

C. Andrew Boswell

CA

46

Publications

3.7K

Citations

30

H-Index

1998

Active since

Affiliations

Mallinckrodt (United States)(Current)

National Cancer Institute

National Institutes of Health

Genentech

Center for Cancer Research

C. Andrew Boswell is an author at Mallinckrodt (United States) specializing in medicine, immunology, and pharmacology.

ORCID

Top concepts

Publications per year

1998–2024

46

Publications

46

Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes

C. Andrew Boswell, Xiankai Sun, Weijun Niu et al. · Journal of Medicinal Chemistry · 2004 · 476 citations

Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants

Nga Bien‐Ly, Yang Yu, Daniela Bumbaca et al. · The Journal of Experimental Medicine · 2014 · 336 citations · Full text

, , +16

Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands

Xiankai Sun, Melinda Wuest, Gary R. Weisman et al. · Journal of Medicinal Chemistry · 2001 · 225 citations

Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats

C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang et al. · Bioconjugate Chemistry · 2011 · 200 citations

, , +23

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor

Rong Deng, Daniela Bumbaca, Cinthia V. Pastuskovas et al. · mAbs · 2016 · 196 citations · Full text

, , +17

Rows per page

1–5 of 46